Late-stage biotech developing treatments for Duchenne muscular dystrophy.
Industry: Health Care
First Day Return: +48.1%
IPO Data | |
---|---|
IPO Date | 06/27/2013 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $78 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Leiden, Netherlands |
Founded | 2002 |
Employees at IPO | 85 |
Website www.prosensa.com |